Debt to EBITDA ratio Analysis of Janux Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of JANX
Dec-23-0.0250Very Poor Debt to EBITDA | Dec-22-0.0118Very Poor Debt to EBITDA | Growth-110.69% |
Debt to EBITDA Analysis of Janux Therapeutics Inc
| Debt to EBITDA Ratio of JANX drastically fell by -110.69 % this year. |
| Debt to EBITDA Ratio with value of -0.0059 was highest in Year Dec-21 in last Five Years. |
| Debt to EBITDA Ratio with value of -1.06 was lowest in Year Dec-19 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.0250 is Greater than Average Debt to EBITDA of -0.244 in last five years. |
Other Debt to EBITDA Related Info of JANX that may interest you.
Janux Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| JANX | 42.0 | 42.37 | 0.873 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| No Significant Stability | |
FY - Historical Debt to EBITDA of Janux Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
|---|---|---|---|---|---|
| Debt to EBITDA | -0.0250 | -0.0118 | -0.0059 | -0.114 | -1.06 |
| Change | -110.69 % | -99.53 % | 94.81 % | 89.23 % |
FY Chart of Debt to EBITDA of Janux Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)